Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogen (NEOG) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Neogen (NEOG) over the last 16 years, with Q4 2025 value amounting to -$18.7 million.

  • Neogen's Change in Inventory fell 35020.78% to -$18.7 million in Q4 2025 from the same period last year, while for Nov 2025 it was -$18.0 million, marking a year-over-year decrease of 13793.07%. This contributed to the annual value of $16.1 million for FY2025, which is 7119.34% down from last year.
  • Per Neogen's latest filing, its Change in Inventory stood at -$18.7 million for Q4 2025, which was down 35020.78% from $2.0 million recorded in Q3 2025.
  • In the past 5 years, Neogen's Change in Inventory ranged from a high of $22.7 million in Q1 2024 and a low of -$18.7 million during Q4 2025
  • Moreover, its 5-year median value for Change in Inventory was $5.7 million (2021), whereas its average is $3.4 million.
  • Within the past 5 years, the most significant YoY rise in Neogen's Change in Inventory was 93826.88% (2022), while the steepest drop was 39230.16% (2022).
  • Quarter analysis of 5 years shows Neogen's Change in Inventory stood at $5.1 million in 2021, then plummeted by 392.3% to -$14.8 million in 2022, then surged by 232.53% to $19.6 million in 2023, then tumbled by 61.99% to $7.5 million in 2024, then plummeted by 350.21% to -$18.7 million in 2025.
  • Its Change in Inventory was -$18.7 million in Q4 2025, compared to $2.0 million in Q3 2025 and -$9.0 million in Q2 2025.